Background: Antibiotic-resistant bacteria are a major threat to global health. Older antibiotics have become more or less ineffective as a result of widespread microbial resistance and an urgent need has emerged for the development of new antimicrobial strategies. Acidocin 4356 is a novel antimicrobial bacteriocin peptide produced by ATCC 4356 and capable of confronting the ATCC 27853 infection challenges.
View Article and Find Full Text PDF